Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial
Titel:
Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial
Auteur:
Masi, Gianluca Loupakis, Fotios Salvatore, Lisa Fornaro, Lorenzo Cremolini, Chiara Cupini, Samanta Ciarlo, Andrea Del Monte, Francesca Cortesi, Enrico Amoroso, Domenico Granetto, Cristina Fontanini, Gabriella Sensi, Elisa Lupi, Cristiana Andreuccetti, Michele Falcone, Alfredo